North Carolina – GenXys and Dendi have announced a partnership to provide comprehensive test results and clinical decision support to clinicians nationwide. The collaboration will deliver a tightly-integrated solution that utilizes a technology-driven workflow to interpret pharmacogenomic (PGx) results and recommend the most optimal treatment plans.
GenXys’ offers precision prescribing software and pharmacogenetic interpretations to healthcare professionals and consumers. TreatGx is a Clinical Decision Support System that integrates pharmacogenomic data with a patient’s health record to identify personalized treatment options within a clinician’s workflow. ReviewGx is an automation software product that combines Medication Therapy Management with evidence-based PGx, deprescribing insights, clinical lab data, and other patient-specific information.
“We’ve been very impressed with GenXys and its PGx product.”, says Jihoon Baek, CEO of Dendi. “The PGx market is still very much underserved, and we’re nowhere close to seeing its full potential in the clinical setting. By collaborating with a forward-thinking partner like GenXys, we’re hoping to fill this gap in demand.”
Karl Pringle, CEO of GenXys, highlights that interoperability of patient data is the key to integrating PGx in primary care, and this partnership is monumental in making PGx more accessible in healthcare for everyone. Dendi is a leading software provider for high-complexity diagnostic laboratories that has developed a new platform that challenges and extends the traditional concept of a laboratory information system, calling it a “complete operating system for the lab.”
Dendi, a leading software provider for high-complexity diagnostic laboratories, has developed a modern lab informatics platform that challenges and extends the traditional concept of a laboratory information system (LIS), calling it a “complete operating system for the lab.”
This partnership arrives in a tough market environment where healthcare providers, including diagnostic laboratories, face lower reimbursement rates, staffing issues, and growing competition. Laboratories can differentiate themselves by providing user-friendly and high-utility clinical decision support products that ultimately help prescribers make informed decisions when choosing the right prescriptions for their patients.
About Dendi Software
Dendi LIS is a modern lab informatics platform built for various modalities, including toxicology, clinical chemistry, molecular, PGx, CGx, genomics, and more. Developed by a team of medical lab experts and software developers, Dendi LIS supports high-volume and novel testing workflows, catering to the evolving needs of modern labs. Designed for interoperability, Dendi seamlessly interfaces with any instruments and analyzers, EHR/EMRs, or third-party services, allowing labs to connect with what they need to stay future-proof. Learn more at www.dendisoftware.com.
Inquiries and Demo Requests: hello@dendisoftware.com
About GenXys Health Care Systems
GenXys, with a presence across North America, provides the world’s most comprehensive precision prescribing solutions with embedded pharmacogenetics to solve one of healthcare’s biggest challenges: inappropriate (“trial-and-error”) prescribing. GenXys’ clinical decision support software suite is in use by major insurance providers, health systems, pharmacies and their pharmacogenetic labs across North America. Ongoing global clinical studies are paving the way into geographical markets to enable GenXys to realize its vision of making every prescription better with its software to increase patient safety, improve population health, and reduce healthcare costs. Learn more at www.genxys.com.
Contact:
Media Relations and Interview Requests: media@genxys.com